FGFR1 and acute myeloid leukemia: This inferior prognosis associated with high GZMB and FLT3 expression levels, but not with FGFR1 or KIT, was further confirmed in the independent AML patient samples from the TCGA panCancer Atlas (Supplement Figure 5).